Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non‐small cell lung cancer

The purpose of this study is to determine the recommended dose (RD) of proton beam therapy (PBT) for inoperable stage III non‐small cell lung cancer (NSCLC). We tested two prescribed doses of PBT: 66 Gy (relative biological effectiveness [RBE]) in 33 fractions and 74 Gy (RBE) in 37 fractions in arms...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Hideyuki, Fuji, Hiroshi, Ono, Akira, Kenmotsu, Hirotsugu, Naito, Tateaki, Yamashita, Haruo, Asakura, Hirofumi, Nishimura, Tetsuo, Takahashi, Toshiaki, Murayama, Shigeyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946725/
https://www.ncbi.nlm.nih.gov/pubmed/27110950
http://dx.doi.org/10.1111/cas.12955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946725/
https://www.ncbi.nlm.nih.gov/pubmed/27110950
http://dx.doi.org/10.1111/cas.12955

Ejemplares similares